Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 12 de 12
Filtrar
1.
Hum Mol Genet ; 22(23): 4661-72, 2013 Dec 01.
Artículo en Inglés | MEDLINE | ID: mdl-23821646

RESUMEN

Facioscapulohumeral muscular dystrophy is a dominantly inherited myopathy associated with chromatin relaxation of the D4Z4 macrosatellite array on chromosome 4. DUX4 is encoded within each unit of the D4Z4 array where it is normally transcriptionally silenced and packaged as constitutive heterochromatin. Truncation of the array to less than 11 D4Z4 units (FSHD1) or mutations in SMCHD1 (FSHD2) results in chromatin relaxation and a small percentage of cultured myoblasts from these individuals exhibit infrequent bursts of DUX4 expression. There are no cellular or animal models to determine the trigger of the DUX4 producing transcriptional bursts and there has been a failure to date to detect the protein in significant numbers of cells from FSHD-affected individuals. Here, we demonstrate for the first time that myotubes generated from FSHD patients express sufficient amounts of DUX4 to undergo DUX4-dependent apoptosis. We show that activation of the Wnt/ß-catenin signaling pathway suppresses DUX4 transcription in FSHD1 and FSHD2 myotubes and can rescue DUX4-mediated myotube apoptosis. In addition, reduction of mRNA transcripts from Wnt pathway genes ß-catenin, Wnt3A and Wnt9B results in DUX4 activation. We propose that Wnt/ß-catenin signaling is important for transcriptional repression of DUX4 and identify a novel group of therapeutic targets for the treatment of FSHD.


Asunto(s)
Apoptosis , Proteínas de Homeodominio/metabolismo , Fibras Musculares Esqueléticas/fisiología , Distrofia Muscular Facioescapulohumeral/genética , Vía de Señalización Wnt , Animales , Línea Celular , Células Cultivadas , Regulación de la Expresión Génica , Técnicas de Silenciamiento del Gen , Proteínas de Homeodominio/genética , Humanos , Ratones , ARN Interferente Pequeño/genética
2.
Mol Ther ; 20(2): 417-23, 2012 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-22146344

RESUMEN

Previous studies have demonstrated that mesenchymal stromal cells (MSCs) enhance cell survival through upregulation and secretion of stanniocalcin-1 (STC1). This study shows that MSC-derived STC1 promotes survival of lung cancer cells by uncoupling oxidative phosphorylation, reducing intracellular reactive oxygen species (ROS), and shifting metabolism towards a more glycolytic metabolic profile. MSC-derived STC1 upregulated uncoupling protein 2 (UCP2) in injured A549 cells in an STC1-dependent manner. Knockdown of UCP2 reduced the ability of MSCs and recombinant STC1 (rSTC1) to reduce cell death in the A549 population. rSTC1-treated A549 cells displayed decreased levels of ROS, mitochondrial membrane potential (MMP), and increased lactate production, all of which were dependent on the upregulation of UCP2. Our data suggest that MSCs can promote cell survival by regulating mitochondrial respiration via STC1.


Asunto(s)
Apoptosis , Glicoproteínas/metabolismo , Células Madre Mesenquimatosas/metabolismo , Neoplasias/metabolismo , Especies Reactivas de Oxígeno/metabolismo , Anaerobiosis , Apoptosis/efectos de los fármacos , Comunicación Autocrina/genética , Glucólisis , Glicoproteínas/genética , Humanos , Canales Iónicos/genética , Canales Iónicos/metabolismo , Proteínas Mitocondriales/genética , Proteínas Mitocondriales/metabolismo , Neoplasias/genética , Comunicación Paracrina/genética , Especies Reactivas de Oxígeno/farmacología , Proteína Desacopladora 2
3.
Virol J ; 8: 461, 2011 Oct 05.
Artículo en Inglés | MEDLINE | ID: mdl-21975125

RESUMEN

The Epstein-Barr virus (EBV) encoded Latent Membrane Protein 1 (LMP1) has been shown to increase the expression of promyelocytic leukemia protein (PML) and the immunofluorescent intensity of promyelocytic leukemia nuclear bodies (PML NBs). PML NBs have been implicated in the modulation of transcription and the association of reporter plasmids with PML NBs has been implicated in repression of reporter activity. Additionally, repression of various reporters in the presence of LMP1 has been noted. This study demonstrates that LMP1 suppresses expression of reporter activity in a dose responsive manner and corresponds with the LMP1 induced increase in PML NB intensity. Disruption of PML NBs with arsenic trioxide or a PML siRNA restores reporter activity. These data offer an explanation for previously conflicting data on LMP1 signaling and calls attention to the possibility of false-positives and false-negatives when using reporter assays as a research tool in cells expressing LMP1.


Asunto(s)
Infecciones por Virus de Epstein-Barr/metabolismo , Regulación Leucémica de la Expresión Génica/efectos de los fármacos , Regulación Viral de la Expresión Génica/efectos de los fármacos , Herpesvirus Humano 4/metabolismo , Leucemia Promielocítica Aguda/metabolismo , Proteínas Nucleares/antagonistas & inhibidores , Plásmidos/farmacología , Factores de Transcripción/antagonistas & inhibidores , Proteínas Supresoras de Tumor/antagonistas & inhibidores , Proteínas de la Matriz Viral/metabolismo , Trióxido de Arsénico , Arsenicales/farmacología , Línea Celular , Relación Dosis-Respuesta a Droga , Infecciones por Virus de Epstein-Barr/complicaciones , Infecciones por Virus de Epstein-Barr/genética , Infecciones por Virus de Epstein-Barr/virología , Silenciador del Gen/efectos de los fármacos , Genes Reporteros , Herpesvirus Humano 4/genética , Humanos , Cuerpos de Inclusión Intranucleares/genética , Cuerpos de Inclusión Intranucleares/metabolismo , Leucemia Promielocítica Aguda/complicaciones , Leucemia Promielocítica Aguda/genética , Leucemia Promielocítica Aguda/virología , Luciferasas/análisis , Proteínas Nucleares/genética , Proteínas Nucleares/metabolismo , Óxidos/farmacología , Plásmidos/genética , Proteína de la Leucemia Promielocítica , ARN Interferente Pequeño/farmacología , Factores de Transcripción/genética , Factores de Transcripción/metabolismo , Transcripción Genética/efectos de los fármacos , Transfección , Proteínas Supresoras de Tumor/genética , Proteínas Supresoras de Tumor/metabolismo , Proteínas de la Matriz Viral/genética , beta-Galactosidasa/análisis
4.
Stem Cells ; 27(3): 670-681, 2009 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-19267325

RESUMEN

Multipotent stromal cells (MSCs) have been shown to reduce apoptosis in injured cells by secretion of paracrine factors, but these factors were not fully defined. We observed that coculture of MSCs with previously UV-irradiated fibroblasts reduced apoptosis of the irradiated cells, but fresh MSC conditioned medium was unable reproduce the effect. Comparative microarray analysis of MSCs grown in the presence or absence of UV-irradiated fibroblasts demonstrated that the MSCs were activated by the apoptotic cells to increase synthesis and secretion of stanniocalcin-1 (STC-1), a peptide hormone that modulates mineral metabolism and has pleiotrophic effects that have not been fully characterized. We showed that STC-1 was required but not sufficient for reduction of apoptosis of UV-irradiated fibroblasts. In contrast, we demonstrated that MSC-derived STC-1 was both required and sufficient for reduction of apoptosis of lung cancer epithelial cells made apoptotic by incubation at low pH in hypoxia. Our data demonstrate that STC-1 mediates the antiapoptotic effects of MSCs in two distinct models of apoptosis in vitro.


Asunto(s)
Apoptosis , Glicoproteínas/fisiología , Células del Estroma/citología , Células del Estroma/metabolismo , Regulación hacia Arriba , Animales , Apoptosis/efectos de los fármacos , Western Blotting , Línea Celular , Supervivencia Celular , Células Cultivadas , Medios de Cultivo Condicionados/farmacología , Fibroblastos/citología , Fibroblastos/metabolismo , Fibroblastos/efectos de la radiación , Glicoproteínas/metabolismo , Humanos , Concentración de Iones de Hidrógeno , Ratones , Microscopía Fluorescente , Análisis de Secuencia por Matrices de Oligonucleótidos , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Células del Estroma/efectos de los fármacos , Transfección , Rayos Ultravioleta
5.
Mol Cell Biol ; 26(23): 8814-25, 2006 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-16966371

RESUMEN

Whereas the PML protein has been reported to have both transcriptional coactivator and corepressor potential, the contribution of the PML nuclear body (PML NB) itself to transcriptional regulation is not well understood. Here we demonstrate that plasmid DNA artificially tethered to PML or the PML NB-targeting domain of Sp100 is preferentially localized to PML NBs. Using the tethering technique, we targeted a simian virus 40 promoter-driven luciferase reporter plasmid to PML NBs, resulting in the repression of the transgene transcriptional activity. Conversely, the tethering of a cytomegalovirus promoter-containing reporter plasmid resulted in activation. Targeting a minimal eukaryotic promoter did not affect its activity. The expression of targeted promoters could be modulated by altering the cellular concentration of PML NB components, including Sp100 and isoforms of the PML protein. Finally, we demonstrate that ICP0, the promiscuous herpes simplex virus transactivator, increases the level of transcriptional activation of plasmid DNA tethered to the PML NB. We conclude that when PML NB components are artificially tethered to reporter plasmids, the PML NB contributes to the regulation of the tethered DNA in a promoter-dependent manner. Our findings demonstrate that transient transcription assays are sensitive to the subnuclear localization of the transgene plasmid.


Asunto(s)
Estructuras del Núcleo Celular/fisiología , Regulación de la Expresión Génica/fisiología , Genes Reporteros , Proteínas de Neoplasias/fisiología , Proteínas Nucleares/fisiología , Plásmidos , Factores de Transcripción/fisiología , Transcripción Genética , Proteínas Supresoras de Tumor/fisiología , Colorantes Fluorescentes , Células HeLa , Humanos , Indoles , Luciferasas/metabolismo , Plásmidos/genética , Regiones Promotoras Genéticas , Proteína de la Leucemia Promielocítica , Isoformas de Proteínas/genética , Isoformas de Proteínas/fisiología , Transfección , Transgenes
6.
Protein Expr Purif ; 62(2): 223-9, 2008 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-18765283

RESUMEN

We have developed a simple method for isolating and purifying plasma membrane proteins from various cell types. This one-step affinity-chromatography method uses the property of the lectin concanavalin A (ConA) and the technique of magnetic bead separation to obtain highly purified plasma membrane proteins from crude membrane preparations or cell lines. ConA is immobilized onto magnetic beads by binding biotinylated ConA to streptavidin magnetic beads. When these ConA magnetic beads were used to enrich plasma membranes from a crude membrane preparation, this procedure resulted in 3.7-fold enrichment of plasma membrane marker 5'-nucleotidase activity with 70% recovery of the activity in the crude membrane fraction of rat liver. In agreement with the results of 5'-nucleotidase activity, immunoblotting with antibodies specific for a rat liver plasma membrane protein, CEACAM1, indicated that CEACAM1 was enriched about threefold relative to that of the original membranes. In similar experiments, this method produced 13-fold enrichment of 5'-nucleotidase activity with 45% recovery of the activity from a total cell lysate of PC-3 cells and 7.1-fold enrichment of 5'-nucleotidase activity with 33% recovery of the activity from a total cell lysate of HeLa cells. These results suggest that this one-step purification method can be used to isolate total plasma membrane proteins from tissue or cells for the identification of membrane biomarkers.


Asunto(s)
Bioquímica/métodos , Membrana Celular/metabolismo , Concanavalina A/metabolismo , Magnetismo , Proteínas de la Membrana/aislamiento & purificación , Microesferas , Animales , Línea Celular Tumoral , Humanos , Extractos Hepáticos/metabolismo , Proteínas de la Membrana/metabolismo , Ratas , Estreptavidina/metabolismo
7.
Eur J Hum Genet ; 20(2): 185-91, 2012 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-21811308

RESUMEN

Macrosatellite repeats (MSRs) present an extreme example of copy number variation, yet their epigenetic regulation in normal and malignant cells is largely understudied. The CT47 cancer/testis antigen located on human Xq24 is organized as an array of 4.8 kb large units. CT47 is expressed in the testis and in certain types of cancer, but not in non-malignant somatic tissue. We used CT47 as a model to study a possible correlation between copy number variation, epigenetic regulation and transcription originating from MSRs in normal and malignant cells. In lymphoblastoid cell lines and primary fibroblasts, CT47 expression was absent, consistent with the observed heterochromatic structure and DNA hypermethylation of the CT47 promoter. Heterochromatinization of CT47 occurs early during development as human embryonic stem cells show high levels of DNA methylation and repressive chromatin modifications in the absence of CT47 expression. In small-cell lung carcinoma cell lines with low levels of CT47 transcripts, we observed reduced levels of histone 3 lysine 9 trimethylation (H3K9me3) and trimethylated lysine 27 of histone H3 (H3K27me3) without concomitant increase in euchromatic histone modifications. DNA methylation levels in the promoter region of CT47 are also significantly reduced in these cells. This supports a model in which during oncogenic transformation, there is a relative loss of repressive chromatin markers resulting in leaky expression of CT47. We conclude that some MSRs, like CT47 and the autosomal MSRs TAF11-Like, PRR20, ZAV and D4Z4, the latter being involved in facioscapulohumeral muscular dystrophy, seem to be governed by common regulatory mechanisms with their abundant expression mostly being restricted to the germ line.


Asunto(s)
Cromosomas Humanos X , Epigénesis Genética , Proteínas/genética , Secuencias Repetidas en Tándem , Antígenos de Neoplasias , Línea Celular , Cromatina/metabolismo , Metilación de ADN , Femenino , Orden Génico , Heterocromatina/genética , Heterocromatina/metabolismo , Histonas/metabolismo , Humanos , Masculino , Regiones Promotoras Genéticas , ARN Mensajero/metabolismo
8.
PLoS One ; 7(4): e35532, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-22536400

RESUMEN

Facioscapulohumeral Disease (FSHD) is a dominantly inherited progressive myopathy associated with aberrant production of the transcription factor, Double Homeobox Protein 4 (DUX4). The expression of DUX4 depends on an open chromatin conformation of the D4Z4 macrosatellite array and a specific haplotype on chromosome 4. Even when these requirements are met, DUX4 transcripts and protein are only detectable in a subset of cells indicating that additional constraints govern DUX4 production. Since the direction of transcription, along with the production of non-coding antisense transcripts is an important regulatory feature of other macrosatellite repeats, we developed constructs that contain the non-coding region of a single D4Z4 unit flanked by genes that report transcriptional activity in the sense and antisense directions. We found that D4Z4 contains two promoters that initiate sense and antisense transcription within the array, and that antisense transcription predominates. Transcriptional start sites for the antisense transcripts, as well as D4Z4 regions that regulate the balance of sense and antisense transcripts were identified. We show that the choice of transcriptional direction is reversible but not mutually exclusive, since sense and antisense reporter activity was often present in the same cell and simultaneously upregulated during myotube formation. Similarly, levels of endogenous sense and antisense D4Z4 transcripts were upregulated in FSHD myotubes. These studies offer insight into the autonomous distribution of muscle weakness that is characteristic of FSHD.


Asunto(s)
Regulación de la Expresión Génica , Proteínas de Homeodominio/genética , Distrofia Muscular Facioescapulohumeral/genética , Transcripción Genética , Animales , Secuencia de Bases , Sitios de Unión/genética , Células Cultivadas , Cromatina/genética , Cromatina/metabolismo , Células Madre Embrionarias/metabolismo , Genes Reporteros , Proteínas Fluorescentes Verdes/biosíntesis , Proteínas Fluorescentes Verdes/genética , Haplotipos , Proteínas de Homeodominio/metabolismo , Humanos , Ratones , Repeticiones de Microsatélite , Datos de Secuencia Molecular , Familia de Multigenes , Fibras Musculares Esqueléticas/metabolismo , Mutagénesis Sitio-Dirigida , Mioblastos Esqueléticos/metabolismo , Regiones Promotoras Genéticas , ARN sin Sentido/genética , ARN sin Sentido/metabolismo , Sitio de Iniciación de la Transcripción
9.
Nat Genet ; 44(12): 1370-4, 2012 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-23143600

RESUMEN

Facioscapulohumeral dystrophy (FSHD) is characterized by chromatin relaxation of the D4Z4 macrosatellite array on chromosome 4 and expression of the D4Z4-encoded DUX4 gene in skeletal muscle. The more common form, autosomal dominant FSHD1, is caused by contraction of the D4Z4 array, whereas the genetic determinants and inheritance of D4Z4 array contraction-independent FSHD2 are unclear. Here, we show that mutations in SMCHD1 (encoding structural maintenance of chromosomes flexible hinge domain containing 1) on chromosome 18 reduce SMCHD1 protein levels and segregate with genome-wide D4Z4 CpG hypomethylation in human kindreds. FSHD2 occurs in individuals who inherited both the SMCHD1 mutation and a normal-sized D4Z4 array on a chromosome 4 haplotype permissive for DUX4 expression. Reducing SMCHD1 levels in skeletal muscle results in D4Z4 contraction-independent DUX4 expression. Our study identifies SMCHD1 as an epigenetic modifier of the D4Z4 metastable epiallele and as a causal genetic determinant of FSHD2 and possibly other human diseases subject to epigenetic regulation.


Asunto(s)
Proteínas Cromosómicas no Histona/genética , Herencia/genética , Proteínas de Homeodominio/genética , Distrofia Muscular Facioescapulohumeral/genética , Mutación , Adulto , Anciano , Cromosomas Humanos Par 18/genética , Islas de CpG/genética , Metilación de ADN/genética , Epigénesis Genética , Femenino , Haplotipos , Humanos , Masculino , Persona de Mediana Edad
10.
Virology ; 416(1-2): 86-97, 2011 Jul 20.
Artículo en Inglés | MEDLINE | ID: mdl-21605886

RESUMEN

Promyelocytic leukemia protein nuclear bodies (PML NBs) have been implicated in host immune response to viral infection. PML NBs are targeted for degradation during reactivation of herpes viruses, suggesting that disruption of PML NB function supports this aspect of the viral life cycle. The Epstein-Barr virus (EBV) Latent Membrane Protein 1 (LMP1) has been shown to suppress EBV reactivation. Our finding that LMP1 induces PML NB immunofluorescence intensity led to the hypothesis that LMP1 may modulate PML NBs as a means of maintaining EBV latency. Increased PML protein and morphometric changes in PML NBs were observed in EBV infected alveolar epithelial cells and nasopharyngeal carcinoma cells. Treatment with low dose arsenic trioxide disrupted PML NBs, induced expression of EBV lytic proteins, and conferred ganciclovir susceptibility. This study introduces an effective modality to induce susceptibility to ganciclovir in epithelial cells with implications for the treatment of EBV associated pathologies.


Asunto(s)
Arsenicales/farmacología , Células Epiteliales/efectos de los fármacos , Células Epiteliales/virología , Ganciclovir/farmacología , Herpesvirus Humano 4/fisiología , Proteínas Nucleares/metabolismo , Óxidos/farmacología , Factores de Transcripción/metabolismo , Proteínas Supresoras de Tumor/metabolismo , Antivirales/farmacología , Trióxido de Arsénico , Línea Celular Tumoral , Farmacorresistencia Viral , Regulación Viral de la Expresión Génica/fisiología , Humanos , Proteína de la Leucemia Promielocítica , Regulación hacia Arriba , Proteínas de la Matriz Viral/genética , Proteínas de la Matriz Viral/metabolismo
11.
PLoS One ; 5(4): e10237, 2010 Apr 20.
Artículo en Inglés | MEDLINE | ID: mdl-20422040

RESUMEN

BACKGROUND: The epithelial cell response to stress involves the transmission of signals between contiguous cells that can be visualized as a calcium wave. In some cell types, this wave is dependent on the release of extracellular trinucleotides from injured cells. In particular, extracellular ATP has been reported to be critical for the epithelial cell response to stress and has recently been shown to be upregulated in tumors in vivo. METHODOLOGY/PRINCIPAL FINDINGS: Here, we identify stanniocalcin-1 (STC1), a secreted pleiotrophic protein, as a critical mediator of calcium wave propagation in monolayers of pulmonary (A549) and prostate (PC3) epithelial cells. Addition of STC1 enhanced and blocking STC1 decreased the distance traveled by an extracellular ATP-dependent calcium wave. The same effects were observed when calcium was stimulated by the addition of exogenous ATP. We uncover a positive feedback loop in which STC1 promotes the release of ATP from cells in vitro and in vivo. CONCLUSIONS/SIGNIFICANCE: The results indicated that STC1 plays an important role in the early response to mechanical injury by epithelial cells by modulating signaling of extracellular ATP. This is the first report to describe STC1 as a modulator or purinergic receptor signaling.


Asunto(s)
Adenosina Trifosfato/metabolismo , Efecto Espectador , Señalización del Calcio/fisiología , Células Epiteliales/patología , Glicoproteínas/fisiología , Adenosina Trifosfato/farmacología , Señalización del Calcio/efectos de los fármacos , Línea Celular Tumoral , Células Epiteliales/metabolismo , Retroalimentación Fisiológica , Humanos , Transducción de Señal
12.
Am J Pathol ; 169(2): 459-70, 2006 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-16877348

RESUMEN

Excessive wall stretch of distensible hollow organs in cardiovascular and urinary systems can activate matrix metalloproteinases (MMPs), thereby releasing matrix neoepitopes and growth factor ligands, leading to ERK1/2 activation. However, the role of MMPs in mechanotransduction of ERK1/2 signaling in the bladder is unknown. We examined bladders undergoing sustained distension over time, which provides a novel platform for smooth muscle mechanotransduction studies. Bladder distension ex vivo caused increased proliferation and MMP activity. Conditioned medium from distended compared with undistended bladders induced proliferation in bladder smooth muscle cells (BSMCs). When conditioned medium from distended bladders was used to proteolyze collagen type I matrices, matrices augmented BSMC proliferation, which was inhibited if bladders were distended in presence of broad-spectrum MMP inhibitors. Distension of ex vivo bladders also induced ERK1/2 phosphorylation in situ, which was dependent on MMP activity in the intact bladder. Similarly, stretching BSMCs in vitro induced increases in ERK1/2 activation and ERK1/2-dependent proliferation under discrete mechanical conditions, and distension conditioned medium itself induced MMP-dependent ERK1/2 activation in BSMCs. Overall, stretch-induced proliferation and ERK1/2 signaling in bladder tissue and BSMCs likely depend on secreted MMP activity. Identification of intermediaries between MMPs and ERK1/2 may elaborate novel mechanisms underlying mechanotransduction in bladder smooth muscle.


Asunto(s)
Matriz Extracelular/metabolismo , Metaloproteinasas de la Matriz/metabolismo , Mecanotransducción Celular , Proteína Quinasa 1 Activada por Mitógenos/metabolismo , Proteína Quinasa 3 Activada por Mitógenos/metabolismo , Miocitos del Músculo Liso/citología , Miocitos del Músculo Liso/enzimología , Animales , Proliferación Celular , Células Cultivadas , Medios de Cultivo Condicionados , Femenino , Gelatinasas/metabolismo , Sustancias de Crecimiento/metabolismo , Técnicas In Vitro , Modelos Biológicos , Miocitos del Músculo Liso/metabolismo , Ratas , Ratas Sprague-Dawley , Vejiga Urinaria/citología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA